Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Kosan and NCI to clinically develop geldanamycin analogues

Nov. 20, 2002

ENMD-0995 trial for patients with multiple myeloma under way

Nov. 19, 2002

GC-C technology has potential as marker and target for gastric and esophageal cancers

Nov. 19, 2002

Helsinn grants CJ Corp. license and distribution rights for palonosetron in Korea

Nov. 19, 2002

New antiproliferative compounds isolated from fungal species

Nov. 19, 2002

Grant awarded for first clinical trial of squalamine in the treatment of prostate cancer

Nov. 18, 2002

Cell Therapeutics earns milestone payment

Nov. 18, 2002

ChromaVision and NewBiotics to collaborate on cancer therapeutic development

Nov. 18, 2002

Phase II trial of TNFerade initiated in patients with esophageal cancer

Nov. 18, 2002

Chemoprotective agent heads for clinical trials at ProMetic

Nov. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...